Similarly, clinical testing of buspirone for the treatment of alcohol abuse or the management of withdrawal-induced anxiety has led to conflicting results42,43, therefore raising uncertainty towards the efficacy of partial activation of 5-HT1A receptors in the treatment of alcohol use disorders. This evidence concerns the gene HTR1A and alcohol abuse.